Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2022. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4687857018 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurised solution for inhalation | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4687858011 | Ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/actuation pressurized solution for inhalation | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4687861012 | Ipratropium bromide 20 microgram and levalbuterol (as levalbuterol sulfate) 50 microgram/actuation pressurized solution for inhalation | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 4687862017 | Ipratropium bromide 20 microgram and levalbuterol (as levalbuterol sulfate) 50 microgram/actuation pressurised solution for inhalation | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 5074225011 | Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Is a | Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has manufactured dose form | Conventional release pressurized solution for inhalation | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has unit of presentation | Actuation | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has precise active ingredient | Levosalbutamol sulfate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has basis of strength substance | Levosalbutamol | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has presentation strength denominator unit | Actuation | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has precise active ingredient | Ipratropium bromide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has basis of strength substance | Ipratropium bromide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely ipratropium bromide 20 microgram and levosalbutamol (as levosalbutamol sulfate) 50 microgram/1 actuation conventional release pressurized solution for inhalation (clinical drug) | Has presentation strength denominator unit | Actuation | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR